Valeo Financial Advisors, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$157,000
-50.6%
333,574
-38.8%
0.01%
-74.2%
Q4 2019$318,000
+148.4%
544,968
+65.1%
0.03%
+106.7%
Q2 2019$128,000
-30.8%
330,0000.0%0.02%
-31.8%
Q1 2019$185,000
+42.3%
330,0000.0%0.02%
+22.2%
Q4 2018$130,000
-14.5%
330,0000.0%0.02%
-14.3%
Q3 2018$152,000
-1.9%
330,0000.0%0.02%
-4.5%
Q2 2018$155,000330,0000.02%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 291,500$137,0000.14%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$441,0000.14%
CVA Family Office, LLC 1,137,920$535,0000.13%
Cypress Capital Management LLC (WY) 179,525$84,0000.10%
Willis Investment Counsel 2,075,840$976,0000.05%
NTB Financial Corp 146,100$69,0000.05%
SRS Capital Advisors, Inc. 629,172$296,0000.04%
Helen Stephens Group, LLC 117,222$55,0000.04%
COURIER CAPITAL LLC 464,356$218,0000.02%
Western Wealth Management, LLC 946,800$444,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders